Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 63, Issue 10, 2011, Pages 3048-3057

  Ramage, Amy E ^a   Fox, Peter T ^a   Brey, Robin L ^b   Narayana, Shalini ^a   Cykowski, Matthew D ^c   Naqibuddin, Mohammad ^d   Sampedro, Margaret ^d   Holliday, Stephen L ^b   Franklin, Crystal ^c   Wallace, Daniel J ^e   Weisman, Michael H ^e   Petri, Michelle ^d  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FLUORODEOXYGLUCOSE F 18; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; APOPTOSIS; ARTICLE; ATROPHY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FRONTAL CORTEX; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY; WHITE MATTER;

ADULT; AGED; BRAIN; FEMALE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 80053529168     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30458     Document Type: Article

References (51)

1. Trysberg E, Nylen K, Rosengren LE, Tarkowski A,. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003; 48: 2881-7. (Pubitemid 37280617)
2. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 529-35.
3. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
4. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A,. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-500. (Pubitemid 32757599)
5. Santer DM, Yoshio T, Minota S, Moller T, Elkon KB,. Potent induction of IFN-α and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 2009; 182: 1192-201.
6. Appenzeller S, Faria A, Marini R, Costallat LT, Cendes F,. Focal transient lesions of the corpus callosum in systemic lupus erythematosus. Clin Rheumatol 2006; 25: 568-71. (Pubitemid 44137643)
7. Hughes M, Sundgren PC, Fan X, Foerster B, Nan B, Welsh RC, et al. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain. Acta Radiol 2007; 48: 213-22. (Pubitemid 46396995)
8. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ,. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004; 116: 50-3. (Pubitemid 38050027)
9. Love C, Tomas MB, Tronco GG, Palestro CJ,. FDG PET of infection and inflammation. Radiographics 2005; 25: 1357-68. (Pubitemid 41695350)
10. Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 2007; 164: 1072-81. (Pubitemid 47121396)
11. Fayed N, Modrego PJ,. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005; 12: 566-9. (Pubitemid 40603682)
12. Fox PT, Ingham RJ, Ingham JC, Zamarripa F, Xiong JH, Lancaster JL,. Brain correlates of stuttering and syllable production. A PET performance-correlation analysis. Brain 2000; 123: 1985-2004.
13. Petri M,. Disease activity assessment in SLE: do we have the right instruments? Ann Rheum Dis 2007; 66 Suppl 3: iii61-4. (Pubitemid 350032637)
14. Podrazilova L, Peterova V, Olejarova M, Tegzova D, Krasensky J, Seidl Z, et al. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2008; 26: 604-10.
15. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
16. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, et al. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol 2008; 35: 2348-54.
17. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
18. Reeves D, Kane R, Winter K,. Automated Neuropsychological Assessment Metrics (ANAM V3.11a/96) user's manual: clinical and neurotoxicology subset (Report No. NCRF-SR-96-01). San Diego: National Cognitive Foundation; 1996.
19. Delis DC, Kramer JH, Kaplan E, Ober BA,. California verbal learning test, 2nd ed. Pearson; 2000.
20. Shimoyama I, Ninchoji T, Uemura K,. The finger-tapping test: a quantitative analysis. Arch Neurol 1990; 47: 681-4.
21. Grant DA, Berg EA,. Wisconsin Card Sorting Test (WCST). Pittsburgh: Western Psychological Services.
22. Wechsler D,. Wechsler Adult Intelligence Scales: WAIS-IV. Pearson/Psychcorp 2008.
23. Lezak MD,. Neuropsychological Assessment. Oxford: Oxford University Press; 1995.
24. Meyers JE, Meyers KR,. Rey complex figure test and recognition trial professional manual. PAR.
25. Addington D, Addington J, Schissel B,. A depression rating scale for schizophrenics. Schizophr Res 1990; 3: 247-51. (Pubitemid 20228720)
26. Dayal NA, Gordon C, Tucker L, Isenberg DA,. The SLICC damage index: past, present and future. Lupus 2002; 11: 261-5. (Pubitemid 34506733)
27. 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand Suppl 1977; 64: 190-1. (Pubitemid 8142079)
28. Jenkinson M, Bannister PR, Brady JM, Smith SM,. Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825-41. (Pubitemid 35317016)
29. Kochunov P, Lancaster J, Thompson P, Toga AW, Brewer P, Hardies J, et al. An optimized individual target brain in the Talairach coordinate system. Neuroimage 2002; 17: 922-7. (Pubitemid 35317025)
30. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC,. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998; 22: 139-52. (Pubitemid 28087337)
31. Nichols TE, Holmes AP,. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002; 15: 1-25. (Pubitemid 34020610)
32. Lazar NA, Luna B, Sweeney JA, Eddy WF,. Combining brains: a survey of methods for statistical pooling of information. Neuroimage 2002; 16: 538-50. (Pubitemid 34852466)
33. Kao CH, Ho YJ, Lan JL, Changlai SP, Liao KK, Chieng PU,. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999; 42: 61-8.
34. Driver CB, Wallace DJ, Lee JC, Forbess CJ, Pourrabbani S, Minoshima S, et al. Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 59: 332-7. (Pubitemid 351399202)
35. Johnson RT, Richardson EP,. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968; 47: 337-69.
36. Zandman-Goddard G, Chapman J, Shoenfeld Y,. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 36: 297-315. (Pubitemid 46517634)
37. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Llorente L, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1242-50. (Pubitemid 46608649)
38. Mondal TK, Saha SK, Miller VM, Seegal RF, Lawrence DA,. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Brain Behav Immun 2008; 22: 949-59.
39. Appenzeller S, Vasconcelos Faria A, Li LM, Costallat LT, Cendes F,. Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol 2008; 64: 635-43.
40. Emmer BJ, Veer IM, Steup-Beekman GM, Huizinga TW, van der Grond J, van Buchem MA,. Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts. Arthritis Rheum 2010; 62: 3716-21.
41. Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999; 8: 11-9. (Pubitemid 29050214)
42. Appenzeller S, Li LM, Costallat LT, Cendes F,. Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus. Lupus 2007; 16: 963-71.
43. Bosma GP, Middelkoop HA, Rood MJ, Bollen EL, Huizinga TW, van Buchem MA,. Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2665-72. (Pubitemid 36118930)
44. Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU,. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 129-34.
45. Feeney DM, Baron JC,. Diaschisis. Stroke 1986; 17: 817-30. (Pubitemid 16000712)
46. Liu Y, Karonen JO, Nuutinen J, Vanninen E, Kuikka JT, Vanninen RL,. Crossed cerebellar diaschisis in acute ischemic stroke: a study with serial SPECT and MRI. J Cereb Blood Flow Metab 2007; 27: 1724-32. (Pubitemid 47476095)
47. Mohr JP,. Historical observations on functional reorganization. Cerebrovasc Dis 2004; 18: 258-9. (Pubitemid 39279407)
48. Kochunov P, Ramage AE, Lancaster JL, Robin DA, Narayana S, Coyle T, et al. Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage 2009; 45: 17-28.
49. Scolding NJ, Joseph FG,. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol 2002; 28: 173-89. (Pubitemid 34639440)
50. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-9. (Pubitemid 46037520)
51. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33. (Pubitemid 37255038)